(Q33449169)

English

The CMF program for operable breast cancer with positive axillary nodes:Updated analysis on the disease-free interval, site of relapse and drug tolerance

scientific article published on June 1, 1977

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 July 2017

The CMF program for operable breast cancer with positive axillary nodes. Updated analysis on the disease-free interval, site of relapse and drug tolerance (English)

1 reference

Europe PubMed Central

26 July 2017

The CMF program for operable breast cancer with positive axillary nodes:Updated analysis on the disease-free interval, site of relapse and drug tolerance (English)

1 reference

10.1002/1097-0142(197706)39:6<2904::AID-CNCR2820390677>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2904::AID-CNCR2820390677%3E3.0.CO;2-8

20 March 2023

1 reference

10.1002/1097-0142(197706)39:6<2904::AID-CNCR2820390677>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2904::AID-CNCR2820390677%3E3.0.CO;2-8

20 March 2023

author name string

G. Bonadonna

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A326384

20 March 2023

A. Rossi

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A326384

20 March 2023

P. Valagussa

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A326384

20 March 2023

A. Banfi

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A326384

20 March 2023

U. Veronesi

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A326384

20 March 2023

language of work or name

0 references

publication date

1 June 1977

1 reference

Europe PubMed Central

26 July 2017

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197706)39:6%3C2904::AID-CNCR2820390677%3E3.0.CO;2-8

1 reference

10.1002/1097-0142(197706)39:6<2904::AID-CNCR2820390677>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2904::AID-CNCR2820390677%3E3.0.CO;2-8

20 March 2023

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197706)39:6%3C2904::AID-CNCR2820390677%3E3.0.CO;2-8

1 reference

10.1002/1097-0142(197706)39:6<2904::AID-CNCR2820390677>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2904::AID-CNCR2820390677%3E3.0.CO;2-8

20 March 2023

1 reference

Europe PubMed Central

26 July 2017

39

1 reference

Europe PubMed Central

26 July 2017

2904-2915

1 reference

Europe PubMed Central

26 July 2017

6 Suppl

1 reference

Europe PubMed Central

26 July 2017

Combination Chemotherapy for Advanced Breast Cancer: Response and Effect on Survival

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197706%2939%3A6%3C2904%3A%3AAID-CNCR2820390677%3E3.0.CO%3B2-8

21 January 2018

Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer

1

1 reference

10.1002/1097-0142(197706)39:6<2904::AID-CNCR2820390677>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2904::AID-CNCR2820390677%3E3.0.CO;2-8

20 March 2023

Response and survival in advanced breast cancer after two non-cross-resistant combinations

2

1 reference

10.1002/1097-0142(197706)39:6<2904::AID-CNCR2820390677>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2904::AID-CNCR2820390677%3E3.0.CO;2-8

20 March 2023

A controlled study in the use of combined drug therapy for metastatic breast cancer

4

1 reference

10.1002/1097-0142(197706)39:6<2904::AID-CNCR2820390677>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2904::AID-CNCR2820390677%3E3.0.CO;2-8

20 March 2023

Cyclical Combination Chemotherapy for Advanced Breast Carcinoma

5

1 reference

10.1002/1097-0142(197706)39:6<2904::AID-CNCR2820390677>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2904::AID-CNCR2820390677%3E3.0.CO;2-8

20 March 2023

Combination chemotherapy for metastatic breast carcinoma. Prospective comparison of multiple drug therapy with L-phenylalanine mustard

7

1 reference

10.1002/1097-0142(197706)39:6<2904::AID-CNCR2820390677>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2904::AID-CNCR2820390677%3E3.0.CO;2-8

20 March 2023

Single and combination nonhormonal chemotherapy in breast cancer

8

1 reference

10.1002/1097-0142(197706)39:6<2904::AID-CNCR2820390677>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2904::AID-CNCR2820390677%3E3.0.CO;2-8

20 March 2023

Integration of chemotherapy into combined modality treatment of solid tumors VII. Adenocarcinoma of the breast

9

1 reference

10.1002/1097-0142(197706)39:6<2904::AID-CNCR2820390677>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2904::AID-CNCR2820390677%3E3.0.CO;2-8

20 March 2023

Adriamycin plus vincristine compared to and combined with cyclophosphamide, methotrexate, and 5-fluorouracil for advanced breast cancer

10

1 reference

10.1002/1097-0142(197706)39:6<2904::AID-CNCR2820390677>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2904::AID-CNCR2820390677%3E3.0.CO;2-8

20 March 2023

1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings

11

1 reference

10.1002/1097-0142(197706)39:6<2904::AID-CNCR2820390677>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2904::AID-CNCR2820390677%3E3.0.CO;2-8

20 March 2023

Combination chemotherapy with adriamycin and cyclophosphamide for advanced breast cancer

13

1 reference

10.1002/1097-0142(197706)39:6<2904::AID-CNCR2820390677>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2904::AID-CNCR2820390677%3E3.0.CO;2-8

20 March 2023

Ranking procedures for arbitrarily restricted observation.

15

1 reference

10.1002/1097-0142(197706)39:6<2904::AID-CNCR2820390677>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2904::AID-CNCR2820390677%3E3.0.CO;2-8

20 March 2023

Cancer Research

17

17

1098

author name string

Martin

publication date

1957

1 reference

10.1002/1097-0142(197706)39:6<2904::AID-CNCR2820390677>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2904::AID-CNCR2820390677%3E3.0.CO;2-8

20 March 2023

Supplementary Report on Spontaneous Return of Function Following Surgical Section or Excision of the Seventh Cranial Nerve in the Surgery of Parotid Tumors*

18

1 reference

10.1002/1097-0142(197706)39:6<2904::AID-CNCR2820390677>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2904::AID-CNCR2820390677%3E3.0.CO;2-8

20 March 2023

Concepts for systemic treatment of micrometastases

21

1 reference

10.1002/1097-0142(197706)39:6<2904::AID-CNCR2820390677>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2904::AID-CNCR2820390677%3E3.0.CO;2-8

20 March 2023

Cyclophosphamide-Induced Ovarian Failure

23

1 reference

10.1002/1097-0142(197706)39:6<2904::AID-CNCR2820390677>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2904::AID-CNCR2820390677%3E3.0.CO;2-8

20 March 2023

The randomization and stratification of patients to clinical trials

24

1 reference

10.1002/1097-0142(197706)39:6<2904::AID-CNCR2820390677>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2904::AID-CNCR2820390677%3E3.0.CO;2-8

20 March 2023

Identifiers

10.1002/1097-0142(197706)39:6<2904::AID-CNCR2820390677>3.0.CO;2-8

1 reference

Europe PubMed Central

26 July 2017

1 reference

Europe PubMed Central

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33449169&oldid=1855996464"